Search Results - cong+tang

1 Results Sort By:
KRAS Mutant Protein-Protein Interaction Targets and Inhibitors for Cancer Therapy
Application Immunotherapeutic agent and biosensor for KRASG12V mutation in tumor cells. Key Benefits First in class, targeted immunotherapy for patients presented with KRASG12V mutation. Attenuates immune suppression associated with KRASG12V-positive cancers. Market Summary The KRASG12V mutation, representing 85% of all cancer mutations, is...
Published: 11/20/2024   |   Inventor(s): Haian Fu, Cong Tang, Xiulei Mo
Keywords(s): Enzyme/Protein, Immunology/Inflammation, Oncology, Target
Category(s): TechPub Algolia > Drug Discovery, TechPub Algolia > Therapeutics